Literature DB >> 29144158

Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia.

Cormac McCarthy1, Danielle M Dunlea1, Radka Saldova2, Michael Henry3, Paula Meleady3, Oliver J McElvaney1, Brian Marsh4, Pauline M Rudd2, Emer P Reeves1, Noel G McElvaney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29144158     DOI： 10.1164/rccm.201709-1954LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

1.  Alpha-1 Antitrypsin Therapy for Autoimmune Disorders.

Authors:  Sihong Song
Journal:  Chronic Obstr Pulm Dis       Date:  2018-10-05

2.  An oxidation-resistant, recombinant alpha-1 antitrypsin produced in Nicotiana benthamiana.

Authors:  David Z Silberstein; Kalimuthu Karuppanan; Hnin Hnin Aung; Ching-Hsien Chen; Carroll E Cross; Karen A McDonald
Journal:  Free Radic Biol Med       Date:  2018-03-16       Impact factor: 7.376

3.  Reduced 25(OH) Vitamin D Association with Lower Alpha-1-Antitrypsin Blood Levels in Type 2 Diabetic Patients.

Authors:  Virginia M Lindley; Kamal Bhusal; Laura Huning; Steven N Levine; Sushil K Jain
Journal:  J Am Coll Nutr       Date:  2020-04-10       Impact factor: 3.571

4.  Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19.

Authors:  Oliver J McElvaney; Eoin O'Connor; Natalie L McEvoy; Daniel D Fraughan; Jennifer Clarke; Oisín F McElvaney; Cedric Gunaratnam; James O'Rourke; Gerard F Curley; Noel G McElvaney
Journal:  J Cyst Fibros       Date:  2020-11-20       Impact factor: 5.482

5.  Characterization of the Inflammatory Response to Severe COVID-19 Illness.

Authors:  Oliver J McElvaney; Natalie L McEvoy; Oisín F McElvaney; Tomás P Carroll; Mark P Murphy; Danielle M Dunlea; Orna Ní Choileáin; Jennifer Clarke; Eoin O'Connor; Grace Hogan; Daniel Ryan; Imran Sulaiman; Cedric Gunaratnam; Peter Branagan; Michael E O'Brien; Ross K Morgan; Richard W Costello; Killian Hurley; Seán Walsh; Eoghan de Barra; Cora McNally; Samuel McConkey; Fiona Boland; Sinead Galvin; Fiona Kiernan; James O'Rourke; Rory Dwyer; Michael Power; Pierce Geoghegan; Caroline Larkin; Ruth Aoibheann O'Leary; James Freeman; Alan Gaffney; Brian Marsh; Gerard F Curley; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2020-09-15       Impact factor: 21.405

6.  Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.

Authors:  Anup Oommen; Stephen Cunningham; Lokesh Joshi
Journal:  Viruses       Date:  2021-01-08       Impact factor: 5.048

Review 7.  Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein.

Authors:  Urszula Lechowicz; Stefan Rudzinski; Aleksandra Jezela-Stanek; Sabina Janciauskiene; Joanna Chorostowska-Wynimko
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

Review 8.  The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

Authors:  Danielle M Dunlea; Laura T Fee; Thomas McEnery; Noel G McElvaney; Emer P Reeves
Journal:  J Inflamm Res       Date:  2018-03-26

9.  Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.

Authors:  Michael E O'Brien; Laura Fee; Niall Browne; Tomás P Carroll; Paula Meleady; Michael Henry; Karen McQuillan; Mark P Murphy; Mark Logan; Cormac McCarthy; Oliver J McElvaney; Emer P Reeves; Noel G McElvaney
Journal:  Thorax       Date:  2020-01-20       Impact factor: 9.139

10.  C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.

Authors:  Laura T Fee; Debananda Gogoi; Michael E O'Brien; Emer McHugh; Michelle Casey; Ciara Gough; Mark Murphy; Ann M Hopkins; Tomás P Carroll; Noel G McElvaney; Emer P Reeves
Journal:  Biomedicines       Date:  2021-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.